Max Robotics — Global Service Robot Directory + US Certification

About

T. de Rooij is a leading surgical researcher whose work focuses on the clinical implementation and evaluation of minimally invasive pancreatic surgery. Their major contributions center on high-impact randomized trials and large-scale surveys that have reshaped how pancreatic resections are performed. The landmark LEOPARD trial, which has garnered 55 citations, demonstrated that minimally invasive distal pancreatectomy significantly reduces time to functional recovery compared to open surgery, while also providing crucial data on cost-effectiveness and disease-specific quality of life. De Rooij further advanced the field by leading the LAELAPS-3 multicenter training program, which established a structured pathway for safely implementing robotic pancreatoduodenectomy. Their rigorous comparative studies, including pooled analyses of randomized trials using biotissue models, have provided objective evidence on the performance advantages of robotic and 3D-laparoscopic platforms over conventional 2D-laparoscopy for complex pancreatic and biliary anastomoses. Additionally, de Rooij’s pan-European and worldwide surveys have been instrumental in mapping current practices, identifying barriers, and promoting the safe adoption of minimally invasive techniques across surgical communities. Through this combination of clinical trials, training initiatives, and global consensus-building, de Rooij has become a pivotal figure in the evidence-based evolution of pancreatic surgery.